Rebecca T. Hahn

Rebecca T. Hahn's AcademicInfluence.com Rankings

Rebecca T. Hahn

Engineering

#4616

World Rank

#5826

Historical Rank

Cybernetics

#68

World Rank

#74

Historical Rank

Biomedical Engineering

#301

World Rank

#308

Historical Rank

Applied Physics

#1162

World Rank

#1190

Historical Rank

engineering Degrees

Download Badge

Engineering

Rebecca T. Hahn's Degrees

PhD Biomedical Engineering Stanford University
Masters Biomedical Engineering Stanford University

Why Is Rebecca T. Hahn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rebecca T. Hahn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. (2016) (3614)
Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients (2019) (2461)
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. (2017) (1827)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
Two-year outcomes after transcatheter or surgical aortic-valve replacement. (2012) (1727)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (1308)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis (2016) (877)
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. (1999) (678)
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. (2007) (664)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement (2013) (597)
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. (2015) (423)
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (2017) (407)
Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists (2014) (405)
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. (1992) (398)
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. (2013) (392)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. (2015) (366)
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. (2020) (356)
Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis (2013) (338)
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. (2011) (321)
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. (1998) (313)
Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. (2014) (306)
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2016) (301)
Global evaluation of echocardiography in patients with COVID-19 (2020) (286)
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. (2011) (275)
The need for a new tricuspid regurgitation grading scheme. (2017) (267)
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. (2018) (267)
Staging classification of aortic stenosis based on the extent of cardiac damage (2017) (246)
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. (2021) (236)
Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR (2001) (231)
Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. (2015) (230)
Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. (2013) (220)
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). (2013) (219)
Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. (2017) (210)
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. (2019) (208)
Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy (2015) (200)
Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Socie (2019) (198)
Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study (2019) (195)
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. (2014) (191)
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. (2021) (189)
A practical guide to multimodality imaging of transcatheter aortic valve replacement. (2012) (188)
Transcatheter Therapies for Treating Tricuspid Regurgitation. (2016) (187)
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. (2014) (186)
Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. (2014) (186)
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. (2019) (184)
First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. (2015) (175)
Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials (1996) (170)
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis (2016) (161)
Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients (2014) (158)
The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? (2017) (155)
Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. (1996) (152)
Aortic Annular Sizing Using a Novel 3-Dimensional Echocardiographic Method: Use and Comparison With Cardiac Computed Tomography (2014) (151)
State-of-the-Art Review of Echocardiographic Imaging in the Evaluation and Treatment of Functional Tricuspid Regurgitation (2016) (149)
Multimodality Imaging in the Context of Transcatheter Mitral Valve Replacement: Establishing Consensus Among Modalities and Disciplines. (2015) (147)
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. (2021) (144)
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). (2013) (141)
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). (2014) (141)
6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation. (2019) (138)
Basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. (2013) (135)
Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A (2013) (131)
Imaging Assessment of Tricuspid Regurgitation Severity. (2019) (130)
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. (2009) (127)
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. (2014) (124)
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve (2017) (123)
Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. (2015) (121)
Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function. (2019) (117)
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. (2016) (117)
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. (2021) (116)
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation (2015) (111)
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. (2020) (110)
Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR. (2015) (107)
Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. (2013) (104)
Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction. (2017) (95)
Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. (2016) (92)
Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history (2018) (90)
Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. (2014) (89)
Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. (2013) (85)
Anatomy and Physiology of the Tricuspid Valve. (2019) (85)
Impact of Aortic Annulus Size on Valve Hemodynamics and Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: Insights From the PARTNER Trial (2014) (85)
Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. (1996) (84)
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. (2017) (82)
Basic Perioperative Transesophageal Echocardiography Examination: A Consensus Statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists (2013) (82)
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). (2014) (81)
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. (2021) (81)
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. (2019) (80)
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. (2021) (79)
Why is intracardiac echocardiography helpful? Benefits, costs, and how to learn (2013) (79)
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. (2020) (78)
Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement (2016) (76)
Indications for and Findings on Transthoracic Echocardiography in COVID-19 (2020) (75)
A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. (2020) (72)
Left ventricular geometry and function preceding neurally mediated syncope. (2000) (69)
Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus. (2013) (67)
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial (2017) (67)
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease. (2019) (67)
3-Dimensional Echocardiography in Imaging the Tricuspid Valve. (2019) (67)
Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. (2014) (65)
Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy (2015) (64)
Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography. (2010) (64)
Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: results and comparisons to nonlased channels. (1997) (64)
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study). (1999) (62)
Transcatheter treatment for tricuspid valve disease. (2021) (61)
Valvular Heart Disease in Patients ≥80 Years of Age. (2018) (61)
Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement. (2019) (60)
Operator Experience and Procedural Results of Transcatheter Mitral Valve Repair in the United States. (2019) (58)
Morphological Assessment of the Tricuspid Apparatus and Grading Regurgitation Severity in Patients With Functional Tricuspid Regurgitation: Thinking Outside the Box. (2019) (57)
Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Decision-Making in the Operating Room: A Surgery-Based Approach: From the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons (2020) (57)
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. (1999) (57)
Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement (2017) (56)
Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. (2012) (56)
Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (56)
Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement. (2019) (55)
Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials. (2019) (55)
Assessment of paravalvular aortic regurgitation after transcatheter aortic valve replacement: intra-core laboratory variability. (2015) (55)
Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation. (2019) (54)
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis (2020) (54)
Congential Giant Aneurysms of the Left Atrial Appendage: Diagnosis and Management (1996) (54)
Echocardiographic imaging of procedural complications during self-expandable transcatheter aortic valve replacement. (2015) (53)
Flow characteristics of the SAPIEN aortic valve: the importance of recognizing in-stent flow acceleration for the echocardiographic assessment of valve function. (2012) (52)
Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. (2017) (52)
Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature. (2021) (52)
Intraprocedural Imaging of Transcatheter Tricuspid Valve Interventions. (2019) (51)
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial. (2016) (50)
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients (2020) (49)
Transcathether Valve Replacement and Valve Repair: Review of Procedures and Intraprocedural Echocardiographic Imaging. (2016) (48)
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation. (2020) (48)
Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions. (2018) (47)
Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. (2018) (46)
Hybrid Imaging During Transcatheter Structural Heart Interventions (2015) (46)
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. (2017) (46)
A three-dimensional echocardiographic study on aortic-mitral coupling in transcatheter aortic valve replacement. (2013) (45)
Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. (2020) (44)
Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. (2020) (44)
Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation. (2020) (42)
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. (2015) (40)
Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. (2015) (40)
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. (2018) (38)
The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA (2018) (38)
Accurate Measurement of Left Ventricular Outflow Tract Diameter: Comment on the Updated Recommendations for the Echocardiographic Assessment of Aortic Valve Stenosis. (2017) (37)
Injuries to the Aorta, Aortic Annulus, and Left Ventricle During Transcatheter Aortic Valve Replacement: Management and Outcomes. (2017) (36)
Echocardiographic Imaging for Transcatheter Aortic Valve Replacement (2018) (36)
Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review. (2020) (36)
Mid-term follow up of mitral valve reconstruction due to active infective endocarditis. (2000) (36)
Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis (2017) (36)
CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. (2017) (35)
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic (2020) (35)
Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. (2015) (35)
Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography. (2021) (34)
Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study. (2020) (33)
Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve-in-Valve Procedures. (2015) (33)
How Do We Reconcile Echocardiography, Computed Tomography, and Hybrid Imaging in Assessing Discordant Grading of Aortic Stenosis Severity? (2019) (33)
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? (2018) (32)
Optimizing Cardiac CT Protocols for Comprehensive Acquisition Prior to Percutaneous MV and TV Repair/Replacement. (2020) (32)
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. (2022) (32)
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. (2012) (32)
Quantifying Tricuspid Regurgitation Severity: A Comparison of Proximal Isovelocity Surface Area and Novel Quantitative Doppler Methods. (2019) (31)
Very low intravenous contrast volume protocol for computed tomography angiography providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic kidney disease. (2016) (31)
Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review. (2019) (31)
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes. (2021) (30)
High Reproducibility in the Interpretation of Intraoperative Transesophageal Echocardiographic Evaluation of Aortic Atheromatous Disease (1996) (30)
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention. (2020) (30)
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. (2019) (30)
Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement. (2019) (30)
Moderate Aortic Stenosis and Heart Failure With Reduced Ejection Fraction: Can Imaging Guide Us to Therapy? (2019) (30)
Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance. (2019) (29)
Alteration in subendocardial and subepicardial myocardial strain in patients with aortic valve stenosis: an early marker of left ventricular dysfunction? (2012) (29)
Periaortic hematoma after transcatheter aortic valve replacement: Description of a new complication (2012) (28)
Practical determination of aortic valve calcium volume score on contrast-enhanced computed tomography prior to transcatheter aortic valve replacement and impact on paravalvular regurgitation: Elucidating optimal threshold cutoffs. (2017) (28)
Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study (2021) (28)
Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation Is Associated With Right Ventricular Reverse Remodeling in Patients With Right-Sided Heart Failure. (2019) (27)
Disproportionate Emphasis on Proportionate Mitral Regurgitation-Are There Better Measures of Regurgitant Severity? (2020) (27)
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies. (2018) (26)
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes. (2021) (26)
Comparison between Three‐Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies (2018) (26)
A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis (2000) (25)
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. (2021) (25)
Accurate measurement of mitral annular area by using single and biplane linear measurements: comparison of conventional methods with the three-dimensional planimetric method. (2012) (25)
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. (2020) (25)
Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review (2020) (25)
Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A. (2017) (24)
Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial. (2021) (24)
Comparison of Transcatheter and Surgical Aortic Valve Replacement in Severe Aortic Stenosis: A Longitudinal Study of Echo Parameters in Cohort A of the PARTNER Trial (2013) (24)
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis (2018) (24)
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. (2021) (24)
Impact of Methodologic Differences in Three‐Dimensional Echocardiographic Measurements of the Aortic Annulus Compared with Computed Tomographic Angiography Before Transcatheter Aortic Valve Replacement (2017) (24)
Assessment of left ventricular function by meridional and circumferential end-systolic stress/minor-axis shortening relations in dilated cardiomyopathy. (1996) (24)
Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System. (2021) (23)
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. (2019) (23)
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacement. (2016) (22)
Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography. (2007) (21)
Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation: Initial Experience With the NaviGate Bioprosthesis. (2018) (20)
Paravalvular leak after transcatheter aortic valve replacement. (2013) (19)
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis. (2021) (19)
Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility. (2016) (19)
Use of imaging for procedural guidance during transcatheter aortic valve replacement (2013) (18)
Transesophageal echocardiography to diagnose and demonstrate resolution of an acute massive pulmonary embolus. (1992) (18)
A Comprehensive Engineering Analysis of Left Heart Dynamics After MitraClip in a Functional Mitral Regurgitation Patient (2020) (18)
Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial. (2020) (18)
Transcatheter Aortic Valve Replacement by a Novel Suprasternal Approach. (2018) (18)
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. (2020) (18)
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. (2021) (18)
Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions (2020) (18)
Differences in Pressure Recovery Between Balloon Expandable and Self-expandable Transcatheter Aortic Valves (2019) (17)
Aortic Valve Annular Sizing: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography (2017) (17)
EARLY FEASIBILITY STUDY OF CARDIOBAND TRICUSPID SYSTEM FOR FUNCTIONAL TRICUSPID REGURGITATION: 30 DAY OUTCOMES (2020) (17)
Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor. (1999) (17)
Sex Differences and Similarities in Valvular Heart Disease (2022) (17)
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials (2019) (16)
2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee. (2019) (16)
Prognostic Value of Feature-Tracking Right Ventricular Longitudinal Strain in Severe Functional Tricuspid Regurgitation: A Multicenter Study. (2021) (15)
Interventional Imaging of the Tricuspid Valve. (2018) (15)
Transcatheter Aortic Valve Replacement: Role of Multimodality Imaging in Common and Complex Clinical Scenarios. (2019) (15)
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. (2022) (15)
Transcatheter Mitral Valve Replacement: Design Implications, Potential Pitfalls and Outcomes Assessment (2015) (15)
Aggressive infective endocarditis and the importance of early repeat echocardiographic imaging. (2014) (15)
Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. (2022) (15)
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement. (2022) (14)
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. (2011) (14)
Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures. (2017) (14)
A Rare Case of Lactobacillus acidophilus Presenting as Mitral Valve Bacterial Endocarditis (2005) (13)
Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations (2021) (13)
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. (2018) (13)
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. (2020) (13)
Guidance of Transcatheter Aortic Valve Replacement by Echocardiography (2013) (12)
The MitraClip Procedure-A Comprehensive Review for the Cardiac Anesthesiologist. (2018) (12)
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. (2022) (12)
Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries (2020) (12)
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement (2020) (12)
Percutaneous Mitral Valve Repair: Multi-Modality Cardiac Imaging for Patient Selection and Intra-Procedural Guidance (2019) (11)
Suprasternal and Left Axillary Transcatheter Aortic Valve Replacement in Morbidly Obese Patients. (2018) (11)
Impact of Tricuspid Valve Morphology on Clinical Outcomes After Transcatheter Edge-to-Edge Repair. (2021) (11)
Imaging in patients with severe mitral annular calcification: insights from a multicentre experience using transatrial balloon-expandable valve replacement. (2019) (11)
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. (2022) (11)
Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension: Insights From the TriValve Registry. (2021) (10)
Paravalvular Regurgitation Following Transcutaneous Aortic Valve Replacement: Predictors and Clinical Significance (2014) (10)
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance (2020) (10)
Concomitant transcatheter aortic and mitral valve-in-valve replacements using transfemoral devices via the transapical approach: first case in United States. (2013) (10)
Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry. (2018) (10)
Improving the accuracy of effective orifice area assessment after transcatheter aortic valve replacement: validation of left ventricular outflow tract diameter and pulsed-wave Doppler location and impact of three-dimensional measurements. (2015) (10)
Comparative quantification of primary mitral regurgitation by computer modeling and simulated echocardiography. (2020) (10)
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. (2021) (10)
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. (2022) (10)
Meta-analysis of Incidence, Predictors and Consequences of Clinical and Subclinical Bioprosthetic Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. (2020) (9)
Percutaneous Bicuspidization of the Tricuspid Valve. (2017) (8)
TCT-86 Early Experience with the Trialign System for Transcatheter Tricuspid Valve Repair: A Multicenter Experience. (2016) (8)
REDUCED INCIDENCE OF PROSTHESIS–PATIENT MISMATCH AND ITS SEQUELAE IN TRANSCATHETER VERSUS SURGICAL VALVE REPLACEMENT IN HIGH–RISK PATIENTS WITH SEVERE AORTIC STENOSIS: A PARTNER TRIAL COHORT A ANALYSIS (2013) (8)
Role of Echocardiography in Transcatheter Valvular Heart Disease Interventions (2017) (8)
Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic Review (2021) (8)
Imaging in Structural Heart Disease (2019) (8)
Effect of transthoracic shocks on left ventricular function. (2005) (7)
Focused Cardiac Ultrasound by Nurses in Rural Vietnam (2018) (7)
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses. (2022) (7)
MITRAL REGURGITATION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION FOR DEGENERATED SURGICAL AORTIC BIOPROSTHESIS: INSIGHTS FROM PARTNER 2 VALVE-IN-VALVE REGISTRY (2018) (7)
Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation. (2020) (7)
Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement (2021) (7)
Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach (2020) (7)
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease. (2022) (7)
Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms (2019) (7)
The Tricuspid Valve Relationship With the Right Ventricle and Pulmonary Vasculature. (2019) (7)
Utility of Three-Dimensional Transesophageal Echocardiography for Mitral Annular Sizing in Transcatheter Mitral Valve Replacement Procedures: A Cardiac Computed Tomographic Comparative Study. (2020) (6)
Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3. (2021) (6)
Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve (2021) (6)
Prosthesis-patient mismatch defined by cardiac computed tomography versus echocardiography after transcatheter aortic valve replacement. (2021) (6)
Transcatheter Tricuspid Repair With the Use of 4-Dimensional Intracardiac Echocardiography. (2021) (6)
Current transcatheter devices to treat functional tricuspid regurgitation with discussion of issues relevant to clinical trial design. (2017) (6)
Computational analysis of virtual echocardiographic assessment of functional mitral regurgitation for validation of proximal isovelocity surface area (PISA) methods. (2021) (6)
Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study. (2021) (6)
Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7. (2022) (6)
RATES OF PARAVALVULAR AORTIC REGURGITATION WITH MDCT NOMINAL AREA OVERSIZING OR UNDERSIZING AFTER TRANSCATHETER HEART VALVE REPLACEMENT WITH THE SAPIEN 3: A COMPARISON WITH THE SAPIEN XT (2014) (6)
Mitral prosthetic valve assessment by echocardiographic guidelines. (2013) (6)
Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy (2018) (6)
Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement (2021) (6)
Edge-to-Edge Tricuspid Valve Repair (2020) (5)
Anatomic classification of mitral annular calcification for surgical and transcatheter mitral valve replacement (2021) (5)
Multimodality Imaging in Transcatheter Mitral Interventions: Buzzword or Modern Age Toolbox? (2016) (5)
SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT IN MITRAL ANNULAR CALCIFICATION- A SYSTEMATIC REVIEW (2020) (5)
Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. (2022) (5)
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model. (2018) (5)
The new paradigm for the management of valvular heart disease: the multi-disciplinary heart team. (2011) (5)
Recent advances in echocardiography for valvular heart disease (2015) (5)
Outcomes after Transcatheter and Surgical Aortic Valve Replacement in Intermediate Risk Patients with Preoperative Mitral Regurgitation: Analysis of PARTNER II Randomized Cohort (2018) (5)
Gradient and pressure recovery of a self-expandable transcatheter aortic valve depends on ascending aorta size: In vitro study (2022) (5)
Transcatheter Mitral Valve Replacement Guided by Echocardiographic-CT Scan Fusion: Early Human Clinical Experience. (2020) (5)
Mitraclip Followed by Surgical Aortic Valve Replacement: Hybrid Techniques for Regurgitant Aortic and Mitral Valve Disease. (2016) (5)
Should echocardiographers embrace the FOCUS examination? (2013) (5)
State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL Repair System (2021) (5)
Abstract 13456: Screening for Transthyretin Cardiac Amyloidosis Using 99mTc-Pyrophosphate Scintigraphy in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (4)
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions (2022) (4)
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial. (2022) (4)
Transcatheter Tricuspid Valve Intervention in Patients with Previous Left Valve Surgery. (2021) (4)
The Role of Multimodality Imaging in Transcatheter Aortic Valve Replacement (2019) (4)
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review. (2022) (4)
Multimodality Imaging of the Anatomy of Tricuspid Valve (2021) (4)
Association of echocardiographic aortic root dilatation with aortic dissection: A case control study (2003) (4)
Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes (2018) (4)
Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation. (2022) (4)
Transmitral Gradients Following Transcatheter Edge-to-Edge Repair: Are Mean Gradients Meaningful? (2022) (4)
Commissural Alignment After Transfemoral Transcatheter Aortic Valve Replacement With the JenaValve Trilogy System. (2021) (4)
Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)–a propensity matched analysis (2021) (4)
Tricuspid regurgitation: finally unforgettable! (2019) (4)
927-38 Noninvasive Predictors of Successful Implantation of Transvenous Defibrillator Lead Systems (1995) (3)
1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study. (2022) (3)
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. (2021) (3)
2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. (2020) (3)
The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement. (2019) (3)
Tricuspid Regurgitation: A Voyage of Discovery. (2019) (3)
Electromechanical wave imaging and electromechanical wave velocity estimation in a large animal model of myocardial infarction (2017) (3)
Oral Abstract Sessions * Do we really need 3D echo to access heart valve?: 3D-TTE (2012) (3)
The challenge of preoperative quantification of functional tricuspid regurgitation and of right ventricle function: what information is clinically relevant? (2017) (3)
Clinical and Echocardiographic Characteristics of Flow-Based Classification Following Balloon-Expandable Transcatheter Heart Valve in PARTNER Trials. (2022) (3)
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. (2022) (3)
The “Eyeball Test” for Risk Assessment in Aortic Stenosis: Characterizing Subjective Frailty Using Objective Measures (2018) (3)
Small cell carcinoma of the lung: an incidental finding on routine cardiac imaging. (2010) (3)
TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial. (2016) (3)
Long‐Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End‐Stage Renal Disease (2021) (3)
Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve Interventions (2021) (3)
Transcatheter Left Atrial Appendage Closure Using Preprocedural Computed Tomography and Intraprocedural 4-Dimensional Intracardiac Echocardiography. (2021) (3)
Treatment of Acute Aortic Insufficiency With a Dedicated Device (2021) (3)
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement (2021) (3)
Transcatheter Repair for Patients with Tricuspid Regurgitation. (2023) (3)
Assessment and procedural guidance with echocardiography for transcatheter tricuspid regurgitation devices. (2019) (3)
Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials. (2022) (2)
5938Mortality risk stratification in patients with severe tricuspid regurgitation - Insights from the Tricuspid Regurgitation REgistry (TRuE) (2019) (2)
Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis (2022) (2)
CLINICAL IMPACT OF NEW LEFT BUNDLE BRANCH BLOCK IN INTERMEDIATE RISK PATIENTS UNDERGOING TAVR: AN ANALYSIS OF THE PARTNER II TRIAL AND REGISTRIES (2018) (2)
Surgically Assisted Transcatheter Balloon-Expandable Valve in Inferior Vena Cava for Torrential Tricuspid Regurgitation (2018) (2)
Quantification of mitral regurgitation after transcatheter edge-to-edge repair: Comparison of echocardiography and patient-specific in silico models (2022) (2)
Endpoints for tricuspid regurgitation trans-catheter therapy trials. (2019) (2)
Abstract 23085: 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Bioprostheses (Mitral Valve-in-Valve): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves) (2017) (2)
Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial (2018) (2)
Inter-Ethnic Differences in Cardiovascular Disease (2021) (2)
A Novel Approach to Quantification of Aortic Regurgitation in Left Ventricular Assist Device (2021) (2)
TCT-93 Results From the Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation (2019) (2)
Incidence and Severity of Paravalvular Aortic Regurgitation With Multidetector Computed Tomography Nominal Area Oversizing or Undersizing After Transcatheter Heart Valve Replacement With the Sapien 3 A (2017) (2)
IMPACT OF PREOPERATIVE MODERATE/SEVERE MITRAL REGURGITATION ON PATIENTS UNDERGOING PERCUTANEOUS AND SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (2)
Transcatheter valve-in-valve implantation for early prosthetic valve degeneration in aortic and mitral positions. (2014) (2)
Tricuspid Valve Morphology and Outcome in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair. (2022) (2)
Tricuspid Annular Morphology: Focus on the Forgotten. (2019) (2)
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion. (2023) (2)
TCT-74 SCOUT Study: Trialign results at 30 days from combined US and EU cohort for the treatment of functional TR (2018) (2)
Transthoracic access for transcatheter aortic valve replacement: technique using the Edwards Sapien Retroflex delivery system. (2014) (2)
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. (2016) (2)
Degenerative mitral stenosis: interpreting the meaning of mean gradient. (2020) (2)
Impact of paravalvular leak following transcatheter aortic valve replacement on one-year mortality: analysis of the combined PARTNER cohorts (2013) (2)
Impact of Predilation During Transcatheter Aortic Valve Replacement (2021) (2)
Transcathether Valve Replacement and Valve Repair (2016) (2)
EFFECT OF TRANSCATHETER AORTIC VALVE REPLACEMENT ON THE MITRAL VALVE (2012) (2)
Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation: Two Sides to Every Story. (2021) (2)
Beyond the Valve and into the Muscle: A Review of Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis (2019) (2)
Echocardiography in Clinical Trials for TAVR: Getting to the Core of the Matter. (2015) (2)
Concomitant Angiotensin-Converting Enzyme Inhibition and Thrombolysis in Acute Anterior Myocardial Infarction (1992) (2)
Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve‐in‐Valve Registry (2020) (2)
Imaging of the Tricuspid Valve: Transoesophageal Echocardiography (2018) (2)
Imaging Considerations for Percutaneous Tricuspid Intervention (2017) (2)
The Lotus Valve: Can It Float Above the Muddy Waters? (2018) (2)
Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial". (2020) (1)
FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective Study (2022) (1)
Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-to-Edge Repair: Insights From the TriValve Registry. (2023) (1)
TCT CONNECT-92 Initial Single-Center Experience With Transfemoral Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Regurgitation (2020) (1)
Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement. (2020) (1)
TCT-115 Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience (2013) (1)
Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study (2022) (1)
Comparison of Mitral Valve Replacement and Repair for Degenerative Mitral Regurgitation: a Meta-analysis and Implications for Transcatheter Mitral Procedures (2020) (1)
CHARACTERIZING AND QUANTIFYING MITRAL ANNULAR CALCIFICATION FOR PATIENT-PREDICTIVE MODELING IN THE ERA OF TMVR (2020) (1)
Interventional Echocardiography: A New Specialty Interest Group for American Society of Echocardiography. (2020) (1)
TCT CONNECT-474 Incidence and Impact of Prosthesis–Patient Mismatch after Aortic Valve Replacement in the PARTNER 2 Trial and Registry (2020) (1)
IMPACT OF ACUTE KIDNEY INJURY AFTER SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (1)
TCT CONNECT-497 Incidence and Predictors of Cardiogenic Shock Following Tricuspid Valve Repair or Replacement (2020) (1)
Computational analysis of quantitative echocardiographic assessments of functional mitral regurgitation: Proximal Isovelocity Surface Area methods (2021) (1)
CONCENTRIC LEFT VENTRICULAR REMODELING IS ASSOCIATED WITH LOW-FLOW SEVERE AORTIC STENOSIS AND LESS REVERSE REMODELING AFTER TAVR: A PARTNER 2 TRIAL ANALYSIS (2017) (1)
Abstract 13143: Direct Measurement of Multiple Vena Contracta Areas by Real-time three-dimensional Echocardiography for Assessing Severity of Mitral Regurgitation (2010) (1)
TCT-86 Which patients are undergoing transcatheter tricuspid repair today? An update from the International Multicenter Transcatheter Tricuspid Valve Therapies (TriValve) Registry (2017) (1)
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. (2021) (1)
TCT-863 SCOUT 1 Trial: Impact of Center Experience on Intraprocedural and 30 Day Outcomes (2018) (1)
2000Determinants of progression from none and mild to moderate and severe native tricuspid regurgitation: results from a large-scale echocardiographic study (2017) (1)
ASSESSMENT OF BALLOON-EXPANDABLE TRANSCATHETER HEART VALVE OVERSIZING USING THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY SEMI-AUTOMATION VERSUS. DIRECT PLANIMETRY: ALL METHODS ARE NOT CREATED EQUAL (2016) (1)
TCT-42 Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: An Analysis of the PARTNER 3 Trial (2021) (1)
Recommendations for Special Competency in Echocardiographic Guidance of Structural Heart Disease Interventions: From the American Society of Echocardiography. (2023) (1)
IMPACT OF TRICUSPID REGURGITATION ON OUTCOMES AFTER MITRACLIP TREATMENT OF SECONDARY MITRAL REGURGITATION: RESULTS FROM THE COAPT TRIAL (2020) (1)
Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves: Completing the Quest. (2016) (1)
Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention (2022) (1)
Understanding the anatomy of the mitral valve: attitudinal is unnecessary (2022) (1)
Planning for Success: Pre-procedural Evaluation for Transcatheter Aortic Valve Replacement. (2020) (1)
3D Intracardiac Echocardiography in Mitral Transcatheter Edge-to-Edge Repair (2022) (1)
Assessment of Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement. (2015) (1)
TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study (2019) (1)
Sex-related differences in transcatheter aortic valve replacement outcomes: what do interventionalists need to know? (2015) (1)
1-Year Outcomes of Transcatheter Tricuspid Valve Repair. (2023) (1)
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials. (2023) (1)
TCT-95 The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement: A Report from the PARTNER I Trial (2015) (1)
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis (2021) (1)
Right Ventricular-Pulmonary Arterial Coupling and Outcomes in Heart Failure and Valvular Heart Disease (2021) (1)
TRANSTHYRETIN CARDIAC AMYLOIDOSIS IS PREVALENT AMONG MEN WITH SEVERE AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2016) (1)
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. (2019) (1)
IMPACT OF PULMONARY HYPERTENSION IN PATIENTS UNDERGOING TRANSCATHETER MITRAL VALVE REPAIR FOR SECONDARY MITRAL REGURGITATION: THE COAPT TRIAL (2020) (1)
TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data (2021) (1)
Predicting Outcomes for Isolated Tricuspid Regurgitation: Multimodality Imaging and Clinical Assessment. (2021) (1)
EFFECTIVE ORIFICE AREA REFERENCE VALUES WITH THE DIFFERENT SIZES OF THE SAPIEN 3 BALLOON-EXPANDING TRANSCATHETER AORTIC VALVE (2016) (1)
Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation: Effective Therapy or Elusive Target? (2022) (1)
PREDICTORS OF WORSENING OR PERSISTENT TRICUSPID REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (1)
Transvalvular Pressure Gradients and All-Cause Mortality Following TAVR: A Multicenter Echocardiographic and Invasive Registry. (2022) (1)
TCT CONNECT-2 The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation: 30-Day Outcomes From the CLASP TR Early Feasibility Study (2020) (1)
PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE (2021) (0)
Predict Response to Postop Wall Thickness , Pulmonary Hypertension , and Diastolic Filling Abnormalities erative Biventricular Pacing (2015) (0)
Current Indications for Transcatheter Edge-to-Edge Repair in a Patient With Primary Mitral Regurgitation. (2022) (0)
TCT-105 Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve Replacement (2013) (0)
1285Progression of tricuspid regurgitation over time and outcome: new insights in the natural history (2017) (0)
Faculty Opinions recommendation of Real-time three-dimensional transesophageal echocardiography adds value to transcatheter aortic valve implantation. (2015) (0)
RIGHT ATRIAL PRESSURE IN PULMONARY HYPERTENSION ASSESSMENT IN TRICUSPID REGURGITATION (2023) (0)
Baseline Characteristics and Clinical Outcomes of a Tricuspid Regurgitation Referral Population. (2023) (0)
AUTHORIZATION FOR INSURANCE CLAIM APPEALS (2013) (0)
TCT-614 Simulated Neo-Left Ventricular Outflow Tract predicts Transvalvular Aortic Gradients Following Transatrial Balloon-Expandable Valve Replacement for the Treatment of Severe Mitral Annular Calcification (2017) (0)
TCT-860 Comparison Between Cardiac Computed Tomography and Three-Dimensional Echocardiography for the Evaluation of Patients with Severe Tricuspid Regurgitation (2017) (0)
Reply: Entrapped Leads After Transcatheter Tricuspid Valve Replacement. (2021) (0)
Common Uses of Echocardiography for TAVR (2014) (0)
Valvular Heart Disease Associated With Radiation Therapy: A Contemporary Review (2022) (0)
Anatomy and Physiology of the TricuspidValve (2019) (0)
Valvular Heart Failure due to Tricuspid Regurgitation (2023) (0)
MITRAL ANNULAR AREA: ACCURACY OF SINGLE AND BIPLANE LINEAR MEASUREMENTS COMPARED TO 3D PLANIMETRY (2010) (0)
TCT-74 Baseline Left Ventricular Hypertrophy and 5-Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries (2019) (0)
Sex-Related Differences in Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe AorticStenosis (0)
QUANTITATIVE ASSESSMENT OF MITRAL REGURGITATION IN PATIENTS WITH MULTIPLE REGURGITANT JETS USING PROXIMAL ISOVELOCITY SURFACE AREA: HEAD TO HEAD COMPARISON BETWEEN TWO- VERSUS THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY (2011) (0)
TRANSCATHETER AORTIC VALVE REPLACEMENT RESULTS IN SIGNIFICANT REVERSE REMODELING IN PATIENTS WITH LEFT VENTRICULAR DILATION: A REPORT FROM THE PARTNER I TRIAL (2015) (0)
TCT-707 Three-dimensional Echocardiographic Annular Sizing is Associated with Reduced Rates of Post-dilatation (2013) (0)
TCT CONNECT-1 Early Feasibility Study of the Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes (2020) (0)
Faculty Opinions recommendation of Three-dimensional ultrasound imaging model of mitral valve regurgitation: design and evaluation. (2015) (0)
INCIDENCE AND IMPACT OF ACUTE KIDNEY INJURY (AKI) POST TRANS-CATHETER AORTIC VALVE REPLACEMENT (TAVR) USING THE NEW VALVE ACADEMIC RESEARCH CONSORTIUM (VARC) CRITERIA (2012) (0)
IMPLICATIONS OF WORSENING RIGHT VENTRICULAR FUNCTION FOLLOWING TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER2A (2017) (0)
Abstract 14059: Low Systemic Arterial Pressure and Greater Vascular Stiffness after Transcatheter Aortic Valve Replacement are Independently Associated with Mortality in the PARTNER I Trial and Registry (2014) (0)
EARLY IMPROVEMENT IN FLOW (LEFT VENTRICULAR STROKE VOLUME INDEX) AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN LOW-FLOW AORTIC STENOSIS (2015) (0)
Abstract 18185: Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A (2013) (0)
TCT-731 Varying Pressure Recovery Characteristics Between Balloon Expandable Versus Self Expanding Valves (2019) (0)
HIGH BASELINE VALVULOARTERIAL IMPEDENCE PREDICTS WORSE 1-YEAR OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
MULTI-VESSEL PCI AND CABG DEMONSTRATE SIGNIFICANT IMPROVEMENTS IN POST-PROCEDURE GLOBAL LONGITUDINAL STRAIN AND LEFT VENTRICULAR EJECTION FRACTION (2022) (0)
TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1. (2016) (0)
Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease. (2022) (0)
TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
TCT-856 Impact of Transcatheter Aortic Valve Implantation on Aortic-Mitral Valve Coupling (2012) (0)
30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR) (2018) (0)
Assimilated LVEF: A Bayesian technique combining human intuition with machine measurement for sharper estimates of left ventricular ejection fraction and stronger association with outcomes (2018) (0)
Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair (2022) (0)
An Unusual Cause of Shortness of Breath (2022) (0)
Transcatheter Tricuspid Valve Replacement With Novel Self-Expanding Valve: Secure Fixation in Insecure Anatomy. (2023) (0)
IMPACT OF POSTIMPLANT THERAPY ON CLINICAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS RECEIVING TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE (2021) (0)
DOES PATIENT PROSTHESIS MISMATCH DEFINED BY CT LVOT AREA PREDICT DOWNSTREAM CLINICAL OUTCOMES (2017) (0)
TCT-95 TEE- and Fluoroscopy-Guided WATCHMAN Implantation Without Administration of Iodinated Contrast Material (2021) (0)
Mitral Annulus Calcium Score. (2019) (0)
Incidence, Predictors, and PrognosticImpact of Late Bleeding Complications After Transcatheter Aortic Valve Replacement (0)
Abstract 663: Comparison of Subendocardial and Subepicardial Radial Strain in Patients With Left Ventricular Hypertrophy Secondary to Aortic Valve Stenosis Before and After Aortic Valve Replacement (2009) (0)
Is it Time to Formalize Training for Interventional Echocardiography and Imaging for Structural Heart Disease Procedures? (2021) (0)
COMMISSURAL ALIGNMENT AFTER TRANSFEMORAL DELIVERY OF THE JENAVALVE TRANSCATHETER AORTIC VALVE (2021) (0)
All that glitters is not gold: can videodensitometry replace echocardiography for the assessment of paravalvular aortic regurgitation? (2020) (0)
TCT-786 The Effect of Post-dilatation on Outcome in the PARTNER 2B Trial (2013) (0)
TCT-38 Paravalvular Regurgitation Regression and Impact on 1-year Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 Transcatheter Valve. (2016) (0)
Coronary protection in transcatheter aortic valve replacement: when, how and critical decision making. (2020) (0)
LOW AND ELEVATED B-TYPE NATRIURETIC PEPTIDE LEVELS ARE ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH PRESERVED EJECTION FRACTION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL AND REGISTRIES (2019) (0)
Standardised definitions of transcatheter edge-to-edge repair leaflet adverse events: identifying complications or complicating identification? (2021) (0)
Abstract 18371: Regression of LV Mass After Transcatheter or Surgical Aortic Valve Replacement for Aortic Stenosis in the PARTNER I Trial (2013) (0)
The Normal Aortic Valve Complex (2019) (0)
CHARACTERIZATION OF WATCHMAN FLX DEVICE PROTRUSION INTO THE LEFT ATRIUM AND THE IMPLICATIONS FOR FUTURE TRANSCATHETER MITRAL REPLACEMENT (2023) (0)
Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy. (2022) (0)
Improved Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by Cardiac Computed Tomography Angiography at 45 Days Postimplant. (2022) (0)
TCT CONNECT-128 Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-score Matched Analysis From PARTNER Trials (2020) (0)
Super-Responders and Nonresponders in the COAPT Trial: Not as Simple as Clip or No Clip. (2020) (0)
OUTCOMES OF THE DIFFERENT FLOW/GRADIENT PATTERNS OF AORTIC STENOSIS AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER 2A TRIAL (2017) (0)
THE ALIGNMENT OF TRANSCATHETER AORTIC VALVE NEO-COMMISSURES (ALIGN TAVR) STUDY (2020) (0)
Insights from a clinical heart valve centre: characteristics and management of functional mitral regurgitation (2022) (0)
LEFT VENTRICULAR REMODELING AFTER JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH PURE AORTIC REGURGITATION (2022) (0)
TCT-709 Hemodynamic Outcomes of Post-dilatation in Transcatheter Aortic Valve Replacement (2013) (0)
TCT-744 Quantitative Assessment of Balloon-Expandable Valve Position During Transcatheter Aortic Valve Replacement Using Intraoperative Transesophageal Echocardiography (2013) (0)
Reply: TAVR Versus SAVR or Valve Versus Valve? (2021) (0)
FIVE-YEAR OUTCOMES COMPARING SURGICAL VERSUS TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (0)
Wall Thickness, Pulmonary Hypertension, and Diastolic Filling Abnormalities Predict Response to Postoperative Biventricular Pacing. (2015) (0)
5324Reduction in heart failure admission rate after transcatheter edge-to-edge tricuspid valve repair for severe tricuspid regurgitation (2018) (0)
STRUCTURAL VALVE DETERIORATION OF TRANSCATHETER VERSUS SURGICAL AORTIC VALVES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE PARTNER 2A TRIAL AND SAPIEN 3 INTERMEDIATE RISK REGISTRY (2021) (0)
OUTCOMES OF CONCOMITANT TRANSCATHETER AORTIC VALVE REPLACEMENT AND PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH SEVERE AORTIC STENOSIS AND OBSTRUCTIVE CORONARY ARTERY DISEASE (2015) (0)
ANNULUS ASSESSMENT PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: ANNULUS DIMENSIONS MAY NOT BE LARGEST IN MID-SYSTOLE (2016) (0)
TCT CONNECT-150 Real World Outcomes With Small (20-mm) Balloon Expandable Sapien 3 Valves Compared to Larger Valves (23-, 26-, and 29-mm) (2020) (0)
PATTERNS OF LEFT VENTRICULAR REMODELING IN PATIENTS WITH SEVERE AORTIC STENOSIS IN THE PARTNER TRIAL (2014) (0)
TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
TCT-138 Right Ventricular Remodeling and Clinical Outcomes Following Transcatheter Tricuspid Valve Intervention (2021) (0)
Computed tomography for strain imaging: Behind the echo eight ball? (2018) (0)
THE MYOCARDIAL CONTRACTION FRACTION IS SUPERIOR TO THE VOLTAGE TO MASS RATIO FOR IDENTIFYING TTR CARDIAC AMYLOID IN PATIENTS UNDERGOING TAVR (2016) (0)
Transcatheter aortic valve replacement for native aortic valve stenosis with intentional aortic leaflet laceration & salvage coronary intervention (2020) (0)
Assessment After Surgery or Interventional Procedures on the Aortic Valve (2019) (0)
593 Changes to aortic-mitral coupling in transcatheter aortic valve replacement (2011) (0)
Reply: Pathophysiological Entity or Imaging-Based Risk Score?: A Controversial Interpretation of the Ratio. (2022) (0)
THE PRESENCE OF A PACEMAKER IS ASSOCIATED WITH INCREASED 1 YEAR MORTALITY AND REHOSPITALIZATION IN THE PARTNER TRIAL (2014) (0)
Tricuspid Valve Disease (2019) (0)
TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial. (2016) (0)
Transcatheter Closure of Paravalvular Regurgitation: Case-Based Learning (2016) (0)
Echocardiography in the Evaluation of Coronary Artery Disease (1999) (0)
CLINICAL IMPLICATIONS OF NEW LEFT BUNDLE BRANCH BLOCK: SUB–ANALYSIS FROM THE PARTNER TRIAL (2013) (0)
Topologic Data Analysis and Machine Learning: Defining the Aortic Valvular-Ventricular Disease Terrain. (2021) (0)
Aortic Valve Annular Sizing (2017) (0)
Why You Should Attend (2010) (0)
The Right Heart and Outcomes of Tricuspid Valve Surgery. (2022) (0)
INCIDENCE OF SEVERE DECLINE IN PLATELET COUNT IN PATIENTS TREATED BY TRANSCATHETER AORTIC VALVE REPLACEMENT AND CLINICAL OUTCOME (2013) (0)
Structural and Hemodynamic Integrity of the Implanted TAVR Valve (2014) (0)
Faculty Opinions recommendation of Prognostic value of LV deformation parameters using 2D and 3D speckle-tracking echocardiography in asymptomatic patients with severe aortic stenosis and preserved LV ejection fraction. (2015) (0)
Prevalence of tricuspid regurgitation and its impact on mid-term outcomes : insights from a tertiary referral center (2016) (0)
TCT-663 Anatomic and Procedural Predictors of Paravalvular Leak following Transcatheter Aortic Valve Replacement with a Self-expanding Prosthesis at a High Volume Center Including a Novel Variable of Inflow Expansion (2015) (0)
Contents (2020) (0)
IMPACT OF ANNULAR OVERSIZING ON PARAVALVULAR REGURGITATION AND VALVE HEMODYNAMICS: NEW INSIGHTS FROM THE PARTNER 3 TRIAL (2021) (0)
TCT-2 Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement in Moderate-Risk Patients: A Pooled PARTNER 2 Trial and Registry Study (2019) (0)
TCT-266 Complications of Indwelling Urinary Catheters In Patients Undergoing Transcatheter Aortic Valve Replacement (2017) (0)
TCT-898 Incidence and Impact of Acquired Thrombocytopenia on Bleeding Events and Mortality after Transcatheter Aortic Valve Replacement (TAVR) (2012) (0)
Structural abnormalities defined by three-dimensional echocardiography in patients with right ventricular tachycardia (1998) (0)
TCT CONNECT-488 Two-Year Outcomes of the TRI-REPAIR Study Assessing the Cardioband Tricuspid Valve Reconstruction System for Patients With Functional Tricuspid Regurgitation (2020) (0)
Abstract 4242: Variability in the Shape of Balloon-expandable Transcatheter Aortic Valve Prostheses and its Association with Native Valve Morphology and Subsequent Prosthetic Aortic Regurgitation (2008) (0)
Unearthing the Tunnel (2022) (0)
THE EFFECT OF OVERSIZING ON THE HEMODYNAMIC PERFORMANCE OF THE SAPIEN 3 TRANSCATHETER HEART VALVE (2015) (0)
Avoiding Mistakes of the Past with Tricuspid Regurgitation. (2019) (0)
New ESC/EACTS guideline recommendations for the treatment of secondary mitral regurgitation: reflections on the evidence (2022) (0)
Iatrogenic Atrial Septal Defects After Transseptal Transcatheter Mitral Valve Replacement With a Balloon-Expandable Valve. (2023) (0)
WORSENING TRICUSPID REGURGITATION AND INCREASED MORTALITY AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER2A (2017) (0)
REDUCED BASELINE EJECTION FRACTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR MORTALITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER II TRIALS (2018) (0)
B-PO01-102 PATIENT SELECTION CONSIDERATIONS AND PROCEDURAL OUTCOMES FOR TRICUSPID TRANSCATHETER EDGE-TO-EDGE REPAIR IN PATIENTS WITH RIGHT VENTRICULAR LEADS: THE TRILUMINATE EARLY FEASIBILITY EXPERIENCE (2021) (0)
Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure. (2023) (0)
Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data. (2022) (0)
3D-TEE for Measurement of the Aortic Annulus: a Review of the Literature and Step-By-Step Approach to an Essential Skill (2018) (0)
SHORT-TERM CLINICAL OUTCOMES OF TRANSCATHETER TRICUSPID VALVE REPAIR WITH THE 3RD GENERATION MITRACLIP XTR SYSTEM (2021) (0)
REFINING THE CLASSIFICATION OF SEVERE, SYMPTOMATIC AORTIC STENOSIS USING FLOW AND GRADIENT MEASUREMENTS TO PREDICT OUTCOMES POST-TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
Aortic Valve Congenital Abnormalities and Stenosis (2019) (0)
COMPARISON BETWEEN THREE-DIMENSIONAL ECHOCARDIOGRAPHY AND COMPUTED TOMOGRAPHY FOR TRICUSPID ANNULUS SIZING: IMPLICATIONS FOR THE GRADING OF TRICUSPID REGURGITATION USING THE QUANTITATIVE DOPPLER METHOD (2018) (0)
Reply: Looking for the Most Effective Transcatheter Treatment for Tricuspid Regurgitation: A Long Road. (2021) (0)
ACCURACY OF THE SINGLE-CYCLE LENGTH METHOD FOR CALCULATING AORTIC VALVE AREA IN NON-SINUS RHYTHMS (2014) (0)
TCT-384 The Myocardial Contraction Fraction Predicts Adverse Events after Aortic Valve Replacement: An Analysis of 3,259 Patients from the Pooled PARTNER 2 Database (2017) (0)
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION WITHIN 6 MONTHS PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: A MULTICENTER CENTER STUDY WITH CENTRAL ANGIOGRAPHIC CORE LABORATORY ANALYSIS (2014) (0)
Abstract 18221: Flow Characteristics of CoreValve Transcatheter Aortic Valve: Implications for Calculation of Stroke Volume and Effective Orifice Area (2015) (0)
Treatment Goals for Transcatheter Edge-to-Edge Mitral Valve Repair: Are Optimal Results Always Optimum? (2021) (0)
Changes in cardiac shape in the ischemic porcine heart does not contribute to the improvement in myocardial function following adenovirus-mediated gene transfer of cDNA for vascular endothelial growth factor (1998) (0)
TCT-185 Change in Left Ventricular Diastolic Dysfunction After Transcatheter Aortic Valve Replacement and Outcomes in Patients With Severe Aortic Stenosis (2021) (0)
Transcatheter tricuspid valve repair/replacement (2021) (0)
Echocardiography in Percutaneous Valvular Intervention (2019) (0)
EFFECT OF SEX AND LOW FLOW AFTER SURGICAL OR TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS OF PARTNER 2 AND 3 TRIALS (2022) (0)
TCT-393 Zero-Contrast Watchman FLX Implantation—A Hybrid Echocardiography-Fluoroscopy Technique for Successful Left Atrial Appendage Occlusion Without Iodinated Contrast (2022) (0)
Managing Patients With Moderate Aortic Stenosis. (2023) (0)
THE DOUBLE ENVELOPE TECHNIQUE OVERESTIMATES THE CALCULATED AORTIC VALVE AREA IN PATIENTS WITH SEVERE AORTIC STENOSIS USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (2013) (0)
TCT-51 Impact of anticoagulation therapy on valve hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A pooled analysis of the PARTNER2 trials (2017) (0)
TCT CONNECT-98 Impact of Flow on the Incidence and Prognosis of Prosthesis-Patient Mismatch Following Aortic Valve Replacement in the PARTNER 2 Study and Registry (2020) (0)
TCT-699 Anatomic Deployment Index: A Novel Measure of SAPIEN 3 Transcatheter Heart Valve Performance. (2016) (0)
IMPACT OF PARAVALVULAR REGURGITATION ASSESSED BY A 5-CLASS GRADING SCHEME ON 1-YEAR OUTCOMES IN THE PARTNER-II SAPIEN 3 HIGH RISK / OPERABLE COHORT (2016) (0)
New therapeutic approach for tricuspid regurgitation: Transcatheter tricuspid valve replacement or repair (2023) (0)
TCT-97 Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation following Transcatheter Aortic Valve Replacement (2012) (0)
TCT CONNECT-350 Impact of Right Ventricular-Pulmonary Arterial Coupling in Heart Failure Patients With Functional Mitral Regurgitation: Analysis From the COAPT Trial (2020) (0)
CARDIAC CT PLANNING TO ACHIEVE COMMISSURAL ALIGNMENT WITH THE JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE DELIVERY SYSTEM (2023) (0)
NORMAL REFERENCE VALUES FOR TRANSCATHETER AORTIC VALVE REPLACEMENT WITH THE BALLOON-EXPANDABLE VALVE (2016) (0)
The Authors Reply: Is it Too Early to Predict Effective Orifice Area in the Era of TAVR? (2023) (0)
Tricuspid Leaflet Gap-Reduction Maneuvers During Transcatheter Tricuspid Valve Repair (2023) (0)
TCT-327 Calcium Volume Score on Contrast-Enhanced Computed Tomography Prior to Transcatheter Aortic Valve Replacement: what’s the most accurate threshold cutoff? (2015) (0)
Assessment of Paravalvular Following Transcatheter Aortic Valve Replacement (2015) (0)
Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy orEmbolization (0)
EARLY IMPROVEMENT IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FUNCTION IN TRANSCATHETER COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT (2014) (0)
Faculty of 1000 evaluation for Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2018) (0)
Abstract 10685: Right Ventricular-Pulmonary Arterial Coupling in Heart Failure Patients with Secondary Mitral Regurgitation: Analysis from the COAPT Trial (2021) (0)
TCT-140 Impact of Left Ventricular Mass Regression on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER 1 and 2 Trials and Registries (2019) (0)
THE IMPACT OF SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE SAPIEN 3 REGISTRY (2019) (0)
TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis. (2016) (0)
Transthoracic and Transesophageal Echocardiography in the Catheterization Laboratory (2012) (0)
Transcatheter treatments for tricuspid valve diseases (2020) (0)
TCT-395 A Propensity-Matched Comparison of Suprasternal and Transfemoral Transcatheter Aortic Valve Replacement: Inominate versus Femoral (2018) (0)
Abstract 14570: Aortic-Mitral Coupling in Transcatheter Aortic Valve Implantation: A 3D Echocardiographic Study (2012) (0)
Multi-Modality Imaging in a Hybrid Setting Facilitates Transcatheter Closure of a Traumatic Ventricular Septal Defect (2013) (0)
TCT-255 Net Adverse Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With a History of Remote, Recent, or Concurrent Percutaneous Coronary Intervention (2021) (0)
Sex-Related Differences in the Physiology, Risk, and Outcomes of Transcatheter Aortic Valve Replacement (2017) (0)
Impact of Tricuspid Regurgitation on Clinical Outcomes (2020) (0)
Structural Heart Imaging Survey Highlights: Training, Challenges, and Practice Patterns in Interventional Imaging. (2022) (0)
REDUCTION OF PARA-VALVULAR REGURGITATION WITH POST-DILATATION FOLLOWING BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
THE EFFECT OF MEDICAL THERAPY ON TRICUSPID VALVE ANATOMY IN THE EVALUATION OF TRANSCATHETER TREATMENT OF TRICUSPID REGURGITATION (2023) (0)
Differences in Pressure Recovery Between Balloon Expandable and Self-expandable Transcatheter Aortic Valves (2019) (0)
Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rebecca T. Hahn?

Rebecca T. Hahn is affiliated with the following schools:

Washington University in St. Louis
University of British Columbia
University of Southern California
Stanford University
Columbia University
Harvard University

Rebecca T. Hahn's Academic­Influence.com Rankings

Rebecca T. Hahn's Degrees

Why Is Rebecca T. Hahn Influential?

Rebecca T. Hahn's Published Works

Published Works

What Schools Are Affiliated With Rebecca T. Hahn?

Rebecca T. Hahn's AcademicInfluence.com Rankings